dCROX and ROX Indices Predict Clinical Outcomes in Patients with COVID-19 Pneumonia Treated with High-Flow Nasal Cannula Oxygen Therapy

CONCLUSIONS: ROX index has the highest accuracy for predicting successful weaning from HFNC in patients with COVID-19 pneumonia. dCROX index is the alternative tool for this setting. However, a larger prospective cohort study is needed to verify these indices for determining separation from HFNC therapy. This trial is registered with TCTR20221107004.PMID:38450049 | PMC:PMC10917475 | DOI:10.1155/2024/8880259
Source: Critical Care Research and Practice - Category: Intensive Care Authors: Source Type: research